Berkeley Conference | Identifying and appraising the key variables that will determine if MAP is zoonotic

Berkeley Conference | Identifying and appraising the key variables that will determine if MAP is zoonotic

Dr. Robert Greenstein is a researcher in the Laboratory of Molecular Surgical Research at the VA Medical Center in Bronx, NY. He has written numerous publications on the subject of mycobacteria, and has recently turned his efforts toward the anti-MAP activity of existing Crohn’s disease therapies.

Learn about Dr. Greenstein’s decades of work with MAP, conventional Crohn’s disease treatments and antibiotic resistance. His presentation concludes with a discussion of the proof needed to link MAP with Crohn’s, followed by an audience Q&A session.

Pin It on Pinterest

Share This